Sponsored Links

Ride-Share Reckoning: Tesla Drives Into Uber's Lane



Tesla’s robotaxi ambitions are colliding with Uber’s established ride-share network. The widening valuation gap hinges on whether autonomy can overcome regulatory and execution hurdles.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

 

 

Update your email preferences or unsubscribe here

345 N Reid Place #620
Sioux Falls, SD 57103, United States

The Favela That Built Its Own Postal Service



If you're looking for oversized returns, focus your attention on international companies solving big problems...
Not rendering correctly? View this e-mail as a web page here.

The Favela That Built Its Own Postal Service

By Joel Litman, chief investment officer, Altimetry


The mail stopped at the borders of Paradise City...

In Paraisopolis, space is so tight that an estimated 60,000 to 100,000 residents are crammed into the hillside. Essential services like electricity and gas are often pulled from a spiderweb of illegal, unregulated cables running along the streets.

The government doesn't call the shots here. Instead, the local gang's word is law.

This is the reality of favelas... the informal, low-income urban settlements dotted throughout Brazil. Paraisopolis is one of São Paulo's largest. Like many other favelas, it was started by squatters who built homes on land they didn't officially own.

Life in the favela comes with plenty of challenges. Violent crime runs rampant in certain areas. So does drug use – many of these settlements are drug-trafficking hubs.

But for decades, one of the biggest obstacles in Paraisopolis was something far more mundane...

Logistics.

Favelas were far too dangerous for most delivery companies to enter. Even Brazil's national postal service had a tough time. In addition to the safety risks, most favelas don't have a formal postal code. Often, the streets aren't wide enough for a car to pass through.

Residents relied on their neighbors to help track down packages... or left the favela altogether to go pick them up. It was an accepted inconvenience of living in these settlements.

Then came COVID-19.


Recommended Links:

TOMORROW: 'The Opportunity That Made Me Millions in 1999 Is Reopening'

CNBC dubbed Whitney Tilson "The Prophet," largely thanks to his stunning predictions in 2000 and 2008. Tomorrow, he's sharing an urgent new prediction, which he says could make you as much as 1,000% multiple times – if you're fast. Click here to learn more (includes two free recommendations).


New 'Medical AI' Works 10,000 Times Faster Than Human PhDs

Nvidia CEO Jensen Huang says it will have "the most profound impact" on our lives. Elon Musk describes the underlying tech as "the most disruptive force in history." Anthropic's CEO says it could unlock 100 years of progress... in the next decade alone. And it could ignite a $367 trillion boom for investors who take the right steps today. Click here to learn about the stocks at the center of this new tech.


Suddenly, venturing out to fetch basic goods became a severe health risk. The elderly in particular were at risk. About 70% of favela residents would abandon their online shopping carts because they couldn't get the items delivered.

Nobody from the outside was willing or able to provide a solution.

So instead, residents built one themselves...

In 2020, the folks of Paraisopolis created Favela Brasil Xpress. The community handles the entire logistics operation – sorting boxes, packing vehicles, and hand-delivering orders on bikes or scooters.

Outsiders can't easily navigate the tight corridors and unwritten community rules. But the locals know exactly how to move through the favelas and where each delivery needs to go.

The service's impact has extended far beyond what residents ever expected... Favela Brasil Xpress now oversees about 1,600 door-to-door deliveries each day.

Brazil's postal service finally opened a branch in Paraisopolis. Google even worked with local leaders to map out the favela's homes and give each a virtual address.

If you're reading this from the United States (or much of the developed world), you probably take package delivery for granted. It couldn't be easier to order something from a website... and have it brought to your house in a matter of days.

But we're the lucky ones...

In much of the messy physical world, plenty of hurdles can keep a box out of a customer's hands for weeks... months... or forever.

That's exactly what makes these markets so valuable for investors.

Where infrastructure is weakest, the companies that solve basic problems can grow the fastest. A logistics improvement in the U.S. might shave a few hours off delivery time. In an underserved market, it can unlock an entire economy's worth of demand.

If you're looking for oversized returns, focus your attention on international companies solving big problems in markets where the basics are still missing. That's where you can find big hidden gems.

Regards,

Joel Litman
September 9, 2026


Low Float (NYSE American: SER) Looks To Turn Good Molecules Into Great Medicines



Any content you receive is for information purposes only. Always conduct your own research.

*Sponsored

Low Float (NYSE American: SER) Looks To Turn Good Molecules Into Great Medicines


*Get Our Updates Faster—Tap Here To Receive SMS Alerts*


September 9th

Greetings, Friend!


In late July, Serina Therapeutics, Inc. (NYSE American: SER) announced that it had wrapped up something early.


All eight patients in Cohort 1 of its Phase 1b registrational study of SER-252 were enrolled and dosed, ahead of guidance that had pointed to the end of the third quarter.


Small biotechs miss dates. This one beat one. That is the story in two sentences, and it explains why the technical picture may have flipped.


The Barchart website points to key technical indicators flashing bullish signals.


In fact, at close on Tuesday 11 of 13 indicators triggered.


“Trend Seeker”, the platform's composite signal, has turned positive at maximum strength.


Here is the piece most screens miss.


The float is small. Yahoo Finance puts the public float at roughly 11.15Mn shares. A low float name carries the potential for heightened volatility in both directions, and that potential is significant here.


No big-pharma budget behind this. Sixteen employees. Huntsville, Alabama. One polymer platform, one lead drug, and a trial the FDA has already agreed can count toward a filing.

Key Company Details: Serina Therapeutics, Inc.


Strip out the chemistry and the pitch is plain. Apomorphine works in advanced Parkinson's. Delivering it steadily is the problem.


The POZ Platform attaches the drug to a polyoxazoline polymer engineered to release it along a near-linear curve.


Serina calls the process POZylation.


The goal is continuous dopaminergic coverage from a single or twice-weekly subcutaneous injection, delivered through Enable Injections' enFuse wearable, replacing the peaks and crashes advanced patients live with today.


Agency feedback in August 2025 supported running the study under the 505(b)(2) NDA pathway.


That matters more than it sounds. It means SER-252 can build on what is already known about apomorphine instead of starting from a blank page.


Behind the lead candidate: SER-270 for tardive dyskinesia, SER-214 for early Parkinson's, and POZ-lipids aimed squarely at the PEG immunogenicity problem inside lipid nanoparticles.


Find Sources And More: SER Website. SER Presentation.

Behind The Curtain


Rewind to early July.


Serina had just completed sentinel dosing in Cohort 1. An independent Safety Monitoring Committee reviewed 72 hours of data and recommended dosing continue.


Serina CEO, Steve Ledger, called it “an important early operational milestone.” Two weeks later the cohort was full.


Read the sequence, not the adjectives. Sentinel dosing, committee review, full cohort, all inside a single month, across sites in the United States and Australia, with South Korea and Taiwan planned.

The Shift: From Financing To Read-Out


March is when the money showed up. Serina secured up to $30Mn at $2.25 per share, a 68% premium to the prior close, with warrants struck at $5.00. Premium-priced raises are rare at this size.


Greg Bailey, M.D., led it and took a Co-Chairman seat. His prior work includes Biohaven and Medivation, both later acquired by Pfizer.


June brought Gannet BioChem, a contract developer with more than 30 years in activated polymers, onto the SER-252 program. July brought Farrell Simon, Pharm.D., a commercial executive with Pfizer and Trevi Therapeutics behind her, onto the board.


Money, then manufacturing, then commercial expertise. That is a company arranging itself for something. None of it proves the drug works. All of it means the company will be ready to answer the next question when the data arrives.

(NYSE American: SER) Hits Our Radar With 6 Key Potential Catalysts


#1. Cohort 1 Cleared Early, Escalation Decision Now Pending. A blinded safety review determines the next dose level, and SER has targeted the single-ascending-dose read-out for the first half of 2027.


#2. Eleven Of Thirteen Barchart Studies Currently Reading Bullish. Barchart.com's Opinion page reported 11 of 13 technical indicators it tracks to be triggered at close on Tuesday. This includes the website’s composite “Trend Seeker” indicator.


#3. Fewer Than 12Mn Shares Sit In The Public Float. With approx. 11.15Mn shares in its float, SER screens as a low float idea, meaning the potential for heightened volatility may be significant. 


#4. An Agency-Backed 505(b)(2) Path Instead Of A Blank Slate. Written feedback supports the registrational design, letting SER file on established apomorphine knowledge rather than reconstructing it.


#5. Cash Of $23.0Mn Against A Defined Milestone Calendar. Reported on June 30th, that balance funds the protocol checkpoints SER has already laid out in public.


#6. Two Published Targets Sit Multiples Above The Current Tape. BTIG opened an $8.00 target and Jones Trading has pinned an $11.00 target on SER. Both of these targets represent a potential triple-digit upside for SER from Tuesday’s close.

In Closing


Nothing here is settled. Serina Therapeutics, Inc. (NYSE American: SER) is clinical-stage, and a Phase 1b read-out is the kind of event that resolves one way or the other.


But the pattern this year is hard to argue with...


Guidance set, guidance beaten. A safety committee that keeps saying continue. A manufacturer signed. A board strengthened. A financing done at a premium instead of a discount.


Next up is a dose-escalation decision. After that, four more cohorts and a first-half-2027 read-out.


Consider putting SER on the list and watch the calendar, not the chatter.


We’re initiating coverage on Serina Therapeutics, Inc. (NYSE American: SER).



Stay tuned for updates heading your way shortly. Talk again soon.


All the best,

Dane James

Editor Market Pulse Today


(Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.)


*MarketPulseToday.com (“MarketPulseToday” or “MPT” ) is owned by Thousand Sun Media LLC, MPT is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MPT brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.


Pursuant to an agreement between Thousand Sun Media LLC and TD Media LLC, Thousand Sun Media LLC has been hired for a period beginning on 09/08/2026 and ending on 09/09/2026 to publicly disseminate information about (SER:US) via digital communications. Under this agreement, TD Media LLC has paid Thousand Sun Media LLC seven thousand five hundred USD ("Funds"). To date, including under the previously described agreement, Thousand Sun Media LLC has been paid fifteen thousand USD ("Funds"). These Funds were part of the fifty thousand USD funds that TD Media LLC received from a third party named LFG Equities Corp. who did not receive the Funds directly or indirectly from the Issuer and does not own st-ock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices.


Neither Thousand Sun Media LLC, TD Media LLC and their member own shares of (SER:US).


Please see important disclosure information here: https://marketpulsetoday.com/disclosure/ser-e8asv/#details

Share With Friends

Bookmark and Share
 
recipes for healthy food © 2008 | Créditos: Templates Novo Blogger